324 related articles for article (PubMed ID: 25522378)
21. Virus-Mediated Expression of DREADDs for In Vivo Metabolic Studies.
Rossi M; Cui Z; Nakajima K; Hu J; Zhu L; Wess J
Methods Mol Biol; 2015; 1335():205-21. PubMed ID: 26260603
[TBL] [Abstract][Full Text] [Related]
22. Chemogenetic stimulation of the G
Kim JH; Rahman MH; Lee WH; Suk K
Pharmacol Res Perspect; 2021 Dec; 9(6):e00822. PubMed ID: 34676988
[TBL] [Abstract][Full Text] [Related]
23. Engineering GPCR signaling pathways with RASSLs.
Conklin BR; Hsiao EC; Claeysen S; Dumuis A; Srinivasan S; Forsayeth JR; Guettier JM; Chang WC; Pei Y; McCarthy KD; Nissenson RA; Wess J; Bockaert J; Roth BL
Nat Methods; 2008 Aug; 5(8):673-8. PubMed ID: 18668035
[TBL] [Abstract][Full Text] [Related]
24. Ganglionic GFAP
Xie AX; Lee JJ; McCarthy KD
JCI Insight; 2017 Jan; 2(2):e90565. PubMed ID: 28138563
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural localization of DREADDs in monkeys.
Galvan A; Raper J; Hu X; Paré JF; Bonaventura J; Richie CT; Michaelides M; Mueller SAL; Roseboom PH; Oler JA; Kalin NH; Hall RA; Smith Y
Eur J Neurosci; 2019 Sep; 50(5):2801-2813. PubMed ID: 31063250
[TBL] [Abstract][Full Text] [Related]
26. Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
Ji B; Kaneko H; Minamimoto T; Inoue H; Takeuchi H; Kumata K; Zhang MR; Aoki I; Seki C; Ono M; Tokunaga M; Tsukamoto S; Tanabe K; Shin RM; Minamihisamatsu T; Kito S; Richmond BJ; Suhara T; Higuchi M
J Neurosci; 2016 Nov; 36(45):11544-11558. PubMed ID: 27911758
[TBL] [Abstract][Full Text] [Related]
27. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.
Chen X; Choo H; Huang XP; Yang X; Stone O; Roth BL; Jin J
ACS Chem Neurosci; 2015 Mar; 6(3):476-84. PubMed ID: 25587888
[TBL] [Abstract][Full Text] [Related]
28. Chronic hM3Dq signaling in microglia ameliorates neuroinflammation in male mice.
Binning W; Hogan-Cann AE; Yae Sakae D; Maksoud M; Ostapchenko V; Al-Onaizi M; Matovic S; Lu WY; Prado MAM; Inoue W; Prado VF
Brain Behav Immun; 2020 Aug; 88():791-801. PubMed ID: 32434046
[TBL] [Abstract][Full Text] [Related]
29. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
[TBL] [Abstract][Full Text] [Related]
30. Gs/Gi Regulation of Bone Cell Differentiation: Review and Insights from Engineered Receptors.
Hsiao EC; Millard SM; Nissenson RA
Horm Metab Res; 2016 Nov; 48(11):689-699. PubMed ID: 27643449
[TBL] [Abstract][Full Text] [Related]
31. Illuminating G-Protein-Coupling Selectivity of GPCRs.
Inoue A; Raimondi F; Kadji FMN; Singh G; Kishi T; Uwamizu A; Ono Y; Shinjo Y; Ishida S; Arang N; Kawakami K; Gutkind JS; Aoki J; Russell RB
Cell; 2019 Jun; 177(7):1933-1947.e25. PubMed ID: 31160049
[TBL] [Abstract][Full Text] [Related]
32. Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolution.
Pei Y; Dong S; Roth BL
Curr Protoc Neurosci; 2010 Jan; Chapter 4():Unit 4.33. PubMed ID: 20066658
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the autonomic nervous system and behaviour by acute glial cell Gq protein-coupled receptor activation in vivo.
Agulhon C; Boyt KM; Xie AX; Friocourt F; Roth BL; McCarthy KD
J Physiol; 2013 Nov; 591(22):5599-609. PubMed ID: 24042499
[TBL] [Abstract][Full Text] [Related]
34. Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.
Saloman JL; Scheff NN; Snyder LM; Ross SE; Davis BM; Gold MS
J Neurosci; 2016 Oct; 36(42):10769-10781. PubMed ID: 27798132
[TBL] [Abstract][Full Text] [Related]
35. Chemogenetic Inhibition of Pain Neurons in a Mouse Model of Osteoarthritis.
Miller RE; Ishihara S; Bhattacharyya B; Delaney A; Menichella DM; Miller RJ; Malfait AM
Arthritis Rheumatol; 2017 Jul; 69(7):1429-1439. PubMed ID: 28380690
[TBL] [Abstract][Full Text] [Related]
36. Sustained Gq-Protein Signaling Disrupts Striatal Circuits via JNK.
Bellocchio L; Ruiz-Calvo A; Chiarlone A; Cabanas M; Resel E; Cazalets JR; Blázquez C; Cho YH; Galve-Roperh I; Guzmán M
J Neurosci; 2016 Oct; 36(41):10611-10624. PubMed ID: 27733612
[TBL] [Abstract][Full Text] [Related]
37. Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses.
Schulz R; Korkut-Demirbaş M; Venturino A; Colombo G; Siegert S
Nat Commun; 2022 Aug; 13(1):4728. PubMed ID: 35970889
[TBL] [Abstract][Full Text] [Related]
38. DREADD-based synthetic control of chondrocyte calcium signaling in vitro.
McDonough RC; Shoga JS; Price C
J Orthop Res; 2019 Jul; 37(7):1518-1529. PubMed ID: 30908734
[TBL] [Abstract][Full Text] [Related]
39. Novel designer receptors to probe GPCR signaling and physiology.
Wess J; Nakajima K; Jain S
Trends Pharmacol Sci; 2013 Jul; 34(7):385-92. PubMed ID: 23769625
[TBL] [Abstract][Full Text] [Related]
40. Chemogenetic manipulation of CX3CR1
Zhao S; Zheng J; Wang L; Umpierre AD; Parusel S; Xie M; Dheer A; Ayasoufi K; Johnson AJ; Richardson JR; Wu LJ
Mol Psychiatry; 2023 Jul; 28(7):2857-2871. PubMed ID: 37365239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
